l General Information |
Product Name | CID5721353 |
General description | CID5721353 is a BCL6 inhibitor. |
Synonym | 2-[5-(5-bromo-2-oxo-1H-indol-3-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanedioic acid; BCL6 inhibitor; 79-6 |
Purity | ≥99.0%(HPLC) | CAS Number | 301356-95-6 |
Formula | C15H9BrN2O6S2 | Molecular Weight | 457.28 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Red or dark red solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | Insoluble |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | CID5721353 is a BCL6 inhibitor (Kd = 138 μM). |
l Packaging & Storage |
Packaging | 5mg; 10mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
